Surgical Management of Inflammatory Breast Cancer

Seminars in Oncology

Volumn 35, Issue 1, 2008, Pages 72-77

  Singletary, S Eva ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; METHOTREXATE; PACLITAXEL; TAMOXIFEN; VINCRISTINE;

ADJUVANT THERAPY; ADVANCED CANCER; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST RECONSTRUCTION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; HORMONAL THERAPY; HUMAN; INFLAMMATORY BREAST CANCER; LYMPH NODE DISSECTION; MASTECTOMY; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; SENTINEL LYMPH NODE BIOPSY; TREATMENT CONTRAINDICATION; TREATMENT RESPONSE;

ALGORITHMS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AXILLA; BREAST NEOPLASMS; CARCINOMA; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INFLAMMATION; LYMPH NODE EXCISION; MAMMAPLASTY; MASTECTOMY, SEGMENTAL; TREATMENT OUTCOME;

EID: 39549092102     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2007.11.008     Document Type: Article

References (39)

1. Kell M.R., and Morrow M. Surgical aspects of inflammatory breast cancer. Breast Dis 22 (2005-06) 67-73
2. Haagensen C.D., and Stout A.P. Carcinoma of the breast. III. Results of treatment, 1935-1942. Ann Surg 134 (1951) 151-170
3. Barber Jr. K.W., Dockerty M.B., and Clagett O.T. Inflammatory carcinoma of the breast. Surg Gynecol Obstet 112 (1961) 406-410
4. Bozzetti F., Saccozzi R., De Lena M., et al. Inflammatory cancer of the breast: analysis of 114 cases. J Surg Oncol 18 (1981) 355-361
5. Chambler A.F., Drew P., Hill A.D., et al. Inflammatory breast carcinoma. Surg Oncol 4 (1995) 245-254
6. De Lena M., Zucali R., Viganotti G., et al. Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer. Cancer Chemother Pharmacol 1 (1978) 53-59
7. Krutchik A.N., Buzdar A.U., Blumenschein G.R., et al. Combined chemoimmunotherapy and radiation therapy of inflammatory breast carcinoma. J Surg Oncol 11 (1979) 325-332
8. Pouillart P., Palangie T., Jouve M., et al. Inflammatory breast carcinoma treated with a combination of chemotherapy and radiation therapy. Results of a randomized trial studying the therapeutic role of an immunotherapy with BCG. Bull Cancer 68 (1981) 171-186
9. Rouesse J., Friedman S., Sarrazin D., et al. Primary chemotherapy in the treatment of inflammatory breast carcinoma: a study of 230 cases from the Institut Gustave-Roussy. J Clin Oncol 4 (1986) 1765-1771
10. Koh E.H., Buzdar A.U., Ames F.C., et al. Inflammatory carcinoma of the breast: results of a combined-modality approach-M.D. Anderson Cancer Center experience. Cancer Chemother Pharmacol 27 (1990) 94-100
11. Chevalier B., Bastit P., Graic Y., et al. The Centre H. Becquerel studies in inflammatory non-metastatic breast cancer. Combined modality approach in 178 patients. Br J Cancer 67 (1993) 594-601
12. Palangie T., Mosseri V., Mihura J., et al. Prognostic factors in inflammatory breast cancer and therapeutic implications. Eur J Cancer 30A (1994) 921-927
13. Perez C.A., Fields J.N., Fracasso P.M., et al. Management of locally advanced carcinoma of the breast. II. Inflammatory carcinoma. Cancer 74 Suppl (1994) 466-476
14. Pawlicki M., Skilyszewski J., and Brandys A. Results of combined treatment of patients with locally advanced breast cancer. Tumori 69 (1983) 249-253
15. Brun B., Otmezguine Y., Feuilhade F., et al. Treatment of inflammatory breast cancer with combination chemotherapy and mastectomy versus breast conservation. Cancer 61 (1988) 1096-1103
16. Fields J.N., Perez C.A., Kuske R.R., et al. Inflammatory carcinoma of the breast: treatment results on 107 patients. Int J Radiat Oncol Biol Phys 17 (1989) 149-155
17. Thoms Jr. W.W., McNeese M.D., Fletcher G.H., et al. Multimodal treatment for inflammatory breast cancer. Int J Radiat Oncol Biol Phys 17 (1989) 739-745
18. Mailosel F., Dufour P., Bergerat J.P., et al. Results of initial doxorubicin, 5-fluorouracil, and cyclophosphamide combination chemotherapy for inflammatory carcinoma of the breast. Cancer 65 (1990) 851-855
19. Pisanski T.M., Schaid D.J., Loprinzi C.L., et al. Inflammatory breast cancer: integration of irradiation, surgery, and chemotherapy. Am J Clin Oncol 15 (1992) 376-387
20. Fein D.A., Mendenhall N.P., March R.D., et al. Results of multimodality therapy for inflammatory breast cancer: an analysis of clinical and treatment factors affecting outcome. Am Surg 60 (1994) 220-225
21. Colozza M., Gori S., Mosconi A.M., et al. Induction chemotherapy with cisplatin, doxorubicin, and cyclophosphamide in a combined modality approach for locally advanced and inflammatory breast cancer. Am J Clin Oncol 19 (1996) 10-17
22. Harris E.E., Schultz D., Bertsch H., et al. Ten-year outcome after combined modality therapy for inflammatory breast cancer. Int J Radiat Oncol Biol Phys 55 (2003) 1200-1208
23. Arthur D.W., Schmidt-Ullrich R.K., Friedman R.G., et al. Accelerated superfractionated radiotherapy for inflammatory breast carcinoma: complete response predicts outcome and allows for breast conservation. Int J Radiat Oncol Biol Phys 44 (1999) 289-296
24. De Boer R.H., Allum W.H., Ebbs S.R., et al. Multimodality therapy in inflammatory breast cancer: is there a place for surgery?. Ann Oncol 11 (2000) 1147-1153
25. Swain S.M., Sorace R.A., Bagley C.S., et al. Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer. Cancer Res 47 (1987) 3889-3894
26. Hortobagyi G., Singletary S.E., and Strom E.A. Treatment of locally advanced and inflammatory breast cancer. In: Harris J.R., Lippman M.E., and Morrow M. (Eds). Treatment of locally advanced and inflammatory breast cancer (2000), Lippincott, Williams & Wilkins, Philadelphia 645-660
27. Vlastos G., Fornage B.D., Mirza N.W., et al. The correlation of axillary ultrasonography with histologic breast cancer downstaging after induction chemotherapy. Am J Surg 179 (2000) 446-452
28. Fleming R.Y.D., Asmar L., Buzdar A.U., et al. Effectiveness of mastectomy by response to induction chemotherapy for control in inflammatory breast carcinoma. Ann Surg Oncol 4 (1997) 452-461
29. Curcio L.D., Rupp E., Williams W.L., et al. Beyond palliative mastectomy in inflammatory breast cancer-a reassessment of margin status. Ann Surg Oncol 6 (1999) 249-254
30. Hance K.W., Anderson W.F., Devesa S.S., et al. Trends in inflammatory breast carcinoma incidence and survival: the Surveillance, Epidemiology, and End Results Program at the National Cancer Institute. J Nat Cancer Inst 97 (2005) 966-975
31. Mamounas E.P., Brown A., Anderson S., et al. Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 23 (2005) 2694-2702
32. Stearns V., Ewing A., Slack R., et al. Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann Surg Oncol 9 (2002) 235-242
33. Davis J.T., Brill Y.M., Simmons S., et al. Ultrasound-guided fine-needle aspiration of clinically negative lymph nodes versus sentinel node mapping in patients at high risk for axillary metastasis. Ann Surg Oncol 13 (2006) 1545-1552
34. Hortobagyi G.N., Ames F.C., Buzdar A.U., et al. Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy. Cancer 62 (1988) 2507-2516
35. Hunt K.K., Baldwin B.J., Strom E.A., et al. Feasibility of postmastectomy radiation therapy after TRAM flap breast reconstruction. Ann Surg Oncol 4 (1997) 377-384
36. Williams J.K., Carlson G.W., Bostwick III J., et al. The effects of radiation treatment after TRAM flap breast reconstruction. Plast Reconstr Surg 100 (1997) 1153-1160
37. Evans G.R., Schusterman M.A., Kroll S.S., et al. Reconstruction and the radiated breast: is there a role for implants?. Plast Reconstr Surg 96 (1995) 1111-1115
38. Chin P.L., Anderson J.S., Somlo G., et al. Esthetic reconstruction after mastectomy for inflammatory breast cancer: is it worthwhile?. J Am Coll Surg 190 (2000) 304-309
39. Slavin S.A., Love S.M., and Goldwyn R.M. Recurrent breast cancer following immediate reconstruction with myocutaneous flaps. Plast Reconstr Surg 93 (1994) 1191-1204